152 related articles for article (PubMed ID: 33337354)
21. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization.
Schaible J; Stroszczynski C; Beyer LP; Jung EM
Clin Hemorheol Microcirc; 2019; 73(1):95-104. PubMed ID: 31561349
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous irreversible electroporation (IRE) of hepatic malignant tumours: contrast-enhanced ultrasound (CEUS) findings.
Wiggermann P; Zeman F; Niessen C; Agha A; Trabold B; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2012; 52(2-4):417-27. PubMed ID: 22986756
[TBL] [Abstract][Full Text] [Related]
23. Efficiency of contrast enhanced ultrasound for immediate assessment of ablation status after intraoperative radiofrequency ablation of hepatic malignancies.
da Silva NPB; Beyer LP; Hottenrott MC; Hackl C; Schlitt HJ; Stroszczynski C; Wiggermann P; Jung EM
Clin Hemorheol Microcirc; 2017; 66(4):357-368. PubMed ID: 28598835
[TBL] [Abstract][Full Text] [Related]
24. Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion.
Apfelbeck M; Chaloupka M; Schlenker B; Stief CG; Clevert DA
Clin Hemorheol Microcirc; 2019; 73(1):135-143. PubMed ID: 31561350
[TBL] [Abstract][Full Text] [Related]
25. VueBox® perfusion analysis of contrast-enhanced ultrasound (CEUS) examinations in patients with primary hyperparathyroidism for preoperative detection of parathyroid gland adenoma.
Platz Batista da Silva N; Jung EM; Jung F; Schlitt HJ; Hornung M
Clin Hemorheol Microcirc; 2018; 70(4):423-431. PubMed ID: 30347604
[TBL] [Abstract][Full Text] [Related]
26. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound and Contrast-enhanced Ultrasound Findings after Percutaneous Irreversible Electroporation of Hepatic Malignant Tumors.
Chai W; Xie L; Zhao Q; Cheng C; Tian G; Jiang T; Wu P
Ultrasound Med Biol; 2020 Mar; 46(3):620-629. PubMed ID: 31924420
[TBL] [Abstract][Full Text] [Related]
28. Prostate cancer treatment with Irreversible Electroporation (IRE): Safety, efficacy and clinical experience in 471 treatments.
Guenther E; Klein N; Zapf S; Weil S; Schlosser C; Rubinsky B; Stehling MK
PLoS One; 2019; 14(4):e0215093. PubMed ID: 30986263
[TBL] [Abstract][Full Text] [Related]
29. Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes.
Collettini F; Enders J; Stephan C; Fischer T; Baur ADJ; Penzkofer T; Busch J; Hamm B; Gebauer B
Radiology; 2019 Jul; 292(1):250-257. PubMed ID: 31161973
[TBL] [Abstract][Full Text] [Related]
30. Multimodal ultrasound imaging with conventional B-mode, elastography, and parametric analysis of contrast-enhanced ultrasound (CEUS): A novel approach to assess small bowel manifestation in severe COVID-19 disease.
Tews HC; Kandulski A; Schmid S; Schlosser S; Schirner S; Putz FJ; Cosma L; Gülow K; Müller M; Jung EM
Clin Hemorheol Microcirc; 2022; 82(4):341-360. PubMed ID: 35871323
[TBL] [Abstract][Full Text] [Related]
31. Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer.
Yue WW; Wang S; Xu HX; Sun LP; Guo LH; Bo XW; Li XL; Zhao CK; Wang D; Liu BJ
Clin Hemorheol Microcirc; 2016 Nov; 64(2):177-188. PubMed ID: 27258196
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of power doppler and ultrasound contrast agents in early imaging-based diagnosis of organ-confined prostate cancer: Is it possible to spare cores with contrast-guided biopsy?
Delgado Oliva F; Arlandis Guzman S; Bonillo García M; Broseta Rico E; Boronat Tormo F
Eur J Radiol; 2016 Oct; 85(10):1778-1785. PubMed ID: 27666616
[TBL] [Abstract][Full Text] [Related]
33. Value of contrast-enhanced ultrasound (CEUS) in Focal Liver Lesions (FLL) with inconclusive findings on cross-sectional imaging.
Auer TA; Fischer T; Garcia SRM; Penzkofer T; Jung EM; Hamm B; Lerchbaumer MH
Clin Hemorheol Microcirc; 2020; 74(3):327-339. PubMed ID: 31658052
[TBL] [Abstract][Full Text] [Related]
34. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
[TBL] [Abstract][Full Text] [Related]
35. Contrast-enhanced ultrasound (CEUS) for the evaluation of gallbladder diseases in comparison to cross-sectional imaging modalities and histopathological results.
Negrão de Figueiredo G; Mueller-Peltzer K; Armbruster M; Rübenthaler J; Clevert DA
Clin Hemorheol Microcirc; 2019; 71(2):141-149. PubMed ID: 30584126
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of dynamic effects of therapy-induced changes in microcirculation after percutaneous treatment of vascular malformations using contrast-enhanced ultrasound (CEUS) and time intensity curve (TIC) analyses.
Wiesinger I; Jung W; Zausig N; Wohlgemuth WA; Pregler B; Wiggermann P; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2018; 69(1-2):45-57. PubMed ID: 29630543
[TBL] [Abstract][Full Text] [Related]
37. Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE).
Blazevski A; Amin A; Scheltema MJ; Balakrishnan A; Haynes AM; Barreto D; Cusick T; Thompson J; Stricker PD
World J Urol; 2021 Apr; 39(4):1107-1114. PubMed ID: 32488359
[TBL] [Abstract][Full Text] [Related]
38. The use of contrast-enhanced ultrasound (CEUS) for the diagnostic evaluation of hepatic echinococcosis.
Schwarze V; Mueller-Peltzer K; Negrão de Figueiredo G; Lindner F; Rübenthaler J; Clevert DA
Clin Hemorheol Microcirc; 2018; 70(4):449-455. PubMed ID: 30347607
[TBL] [Abstract][Full Text] [Related]
39. Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation.
Scheltema MJ; Chang JI; van den Bos W; Böhm M; Delprado W; Gielchinsky I; de Reijke TM; de la Rosette JJ; Siriwardana AR; Shnier R; Stricker PD
Eur Urol Focus; 2019 Jul; 5(4):585-591. PubMed ID: 29102671
[TBL] [Abstract][Full Text] [Related]
40. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.
Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ
BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
